For the pre-paid carriers, the Street sees this as a good news: for one thing, it raises the possibility of further consolidation.
FORBES: The AT&T/T-Mobile Deal: Sorting Out The Winners and Losers
Most seriously, there is the scourge of what is called paid news, which involves influential people - mainly politicians - paying newspapers and news channels for positive coverage.
The sale of the Minneapolis paper mirrors the assessment of the Boston Globe by JPMorgan Chase, which reportedly valued that paper at half what the New York Times Co. (nyse: NYT - news - people ) paid for it in 1993.
Crown (nyse: CCK - news - people) has paid dearly for those 93 days, paying out millions of dollars to settle some 70, 000 asbestos-related claims, and bringing the company to the edge of bankruptcy.
So on the morning before the bad news to come the prime minister and his deputy went to school to unveil what they hoped would be viewed as some better news - an increase in investment spending paid for by deeper cuts to day to day departmental budgets.
Harvard researcher Marc Pfeffer, who was paid to help conduct the study for AtheroGenics (nasdaq: AGIX - news - people ), said AGI-1067 "is as promising as anything I have seen" for preventing heart attacks on top of existing cholesterol-lowering and hypertension medicines.
His team paid for "Sponsored Stories" to appear in some users' Facebook news feeds - regardless of whether they wanted to receive them.
Item: Disgraced former governor Elliot Spitzer, who was run out of office for cavorting with high-paid prostitutes, was hired by CNN to host a prime time news show.
News Corp owns the Wall Street Journal, which has one of the most successful paid-for sites with about 407, 000 electronic subscribers.
But on Tuesday, former director of public prosecutions Lord Macdonald, who reviewed for NI's owner News Corporation the e-mails in a file relating to bribes allegedly paid to police, said they contained "evidence of serious criminal offences".
While other pharmaceutical companies have paid large amounts of cash for biotech drugs that had nearly completed human testing, Roche (otc: RHHBY - news - people ) has been sticking mostly to those that are in the earliest (phase I) or middle (phase II) stages of clinical trials.
应用推荐